首页 > 最新文献

Revista Espanola De Quimioterapia最新文献

英文 中文
[Amoebic liver abscess in a patient from Gambia]. [冈比亚患者阿米巴肝脓肿]。
IF 1.9 4区 医学 Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2023-04-01 DOI: 10.37201/req/106.2022
M Callejón Fernández, R Kohan, A M López Lirola, M Lecuona Fernández
{"title":"[Amoebic liver abscess in a patient from Gambia].","authors":"M Callejón Fernández, R Kohan, A M López Lirola, M Lecuona Fernández","doi":"10.37201/req/106.2022","DOIUrl":"https://doi.org/10.37201/req/106.2022","url":null,"abstract":"","PeriodicalId":21232,"journal":{"name":"Revista Espanola De Quimioterapia","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/92/ea/revespquimioter-36-214.PMC10066907.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9237930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Emergency detection of HIV infection in patients consulting for conditions potentially related to occult infection: Initial results of the "Urgències VIHgila" program]. [在咨询可能与隐性感染有关的情况的患者中紧急检测艾滋病毒感染:“紧急VIHgila”计划的初步结果]。
IF 1.9 4区 医学 Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2023-04-01 DOI: 10.37201/req/085.2022
O Miró, E Miró, M Carbó, M Saura, A Rebollo, R de Paz, J M Guardiola, A Smithson, D Iturriza, C Ramió Lluch, C Leey, J I Ferro, A Villamor, E Gené

Objective: To estimate the prevalence of unknown HIV infection in patients who consulted in hospital emergency services (ED) for conditions defined in the SEMES-GESIDA Consensus Document (DC), evaluate the efficiency of its im-plementation and investigate the efficiency of HIV serology determination in other conditions.

Methods: Results were reviewed in 10 Catalan EDs for 12 months (July-21-June-22) after implementing CD recommendations: request HIV serology in case of suspected sexually transmitted infection, chemsex, post-exposure prophylaxis (PEP), mononucleosis syndrome, community pneumonia (18-65 y-o) or herpes zoster (18-65 y-o). Other reasons for request were included. Prevalence (%) of global seropositivity and for each circumstance was calculated, with a 95% confidence interval (95%CI). The efficient strategy was considered if the lower limit of the CI95%>0.1%.

Results: A total of5,107 HIV serologies were performed: 2,847(56%) in situations specified in CD, and 2,266 (44%) in other 138 circumstances. Forty-eight unknown HIV infections were detected (prevalence=0.94%;95%CI=0.69-1.24). The prevalence was somewhat higher in DC requests (30 cas-es 1.12%) than the rest (18 cases 0.71%; p=0.16). The individualized prevalence of CD reasons ranged between 7.41% (95%CI=0.91-24.3) in chemsex and 0.42% 95%CI=0.14-0.98) in PPE, always efficient except herpes zoster (0.76%; CI95%=0.02-4.18). In other reasons, cases were detected in 12 circumstances, and in four the determination could be efficient: lymphopenia (10%;CI95%=0.25-44.5), fever with polyarthralgia-polyarthritis (7.41%;CI95% =0.91-24.3), behavioral alteration-confusion-encephalopathy (3.45%;95%CI=0.42-11.9) and fever of unknown origin (2.50%;95%CI=0.82-5.74).

Conclusions: The determination of HIV serology in HES in the processes defined by DC SEMES-GESIDA is efficient. Some circumstances are identified that could be added to those previously contemplated to increase efficiency.

目的:估计因《sems - gesida共识文件》(DC)定义的疾病到医院急诊就诊的患者中未知HIV感染的患病率,评估其实施效率,并调查其他情况下HIV血清学检测的效率。方法:对10例加泰罗尼亚ed实施CD建议后12个月(7月-21日-6月22日)的结果进行回顾:怀疑性传播感染的患者要求进行HIV血清学检查、化学行为、暴露后预防(PEP)、单核细胞增多症综合征、社区肺炎(18-65岁)或带状疱疹(18-65岁)。提出请求的其他理由也包括在内。计算每种情况下全球血清阳性的患病率(%),95%置信区间(95% ci)。如果CI95%>0.1%,则考虑有效策略。结果:共进行了5107例HIV血清学检查:2847例(56%)在CD指定的情况下,2266例(44%)在其他138种情况下。检出48例未知HIV感染(患病率=0.94%;95%CI=0.69-1.24)。DC请求的患病率(30例1.12%)略高于其他(18例0.71%);p = 0.16)。在化学性别中,CD原因的个体化患病率为7.41% (95%CI=0.91-24.3),在PPE中为0.42% (95%CI= 0.14-0.98),除带状疱疹(0.76%;CI95% = 0.02 - -4.18)。在其他12种情况下检测到病例,其中4种诊断有效:淋巴细胞减少(10%,CI95%=0.25-44.5)、发热伴多关节痛-多关节炎(7.41%,CI95%= 0.91-24.3)、行为改变-精神错乱-脑病(3.45%,95%CI=0.42-11.9)和不明原因发热(2.50%,95%CI=0.82-5.74)。结论:在DC - sems - gesida定义的过程中检测HES的HIV血清学是有效的。还确定了一些可以添加到先前考虑的情况中以提高效率的情况。
{"title":"[Emergency detection of HIV infection in patients consulting for conditions potentially related to occult infection: Initial results of the \"Urgències VIHgila\" program].","authors":"O Miró,&nbsp;E Miró,&nbsp;M Carbó,&nbsp;M Saura,&nbsp;A Rebollo,&nbsp;R de Paz,&nbsp;J M Guardiola,&nbsp;A Smithson,&nbsp;D Iturriza,&nbsp;C Ramió Lluch,&nbsp;C Leey,&nbsp;J I Ferro,&nbsp;A Villamor,&nbsp;E Gené","doi":"10.37201/req/085.2022","DOIUrl":"https://doi.org/10.37201/req/085.2022","url":null,"abstract":"<p><strong>Objective: </strong>To estimate the prevalence of unknown HIV infection in patients who consulted in hospital emergency services (ED) for conditions defined in the SEMES-GESIDA Consensus Document (DC), evaluate the efficiency of its im-plementation and investigate the efficiency of HIV serology determination in other conditions.</p><p><strong>Methods: </strong>Results were reviewed in 10 Catalan EDs for 12 months (July-21-June-22) after implementing CD recommendations: request HIV serology in case of suspected sexually transmitted infection, chemsex, post-exposure prophylaxis (PEP), mononucleosis syndrome, community pneumonia (18-65 y-o) or herpes zoster (18-65 y-o). Other reasons for request were included. Prevalence (%) of global seropositivity and for each circumstance was calculated, with a 95% confidence interval (95%CI). The efficient strategy was considered if the lower limit of the CI95%>0.1%.</p><p><strong>Results: </strong>A total of5,107 HIV serologies were performed: 2,847(56%) in situations specified in CD, and 2,266 (44%) in other 138 circumstances. Forty-eight unknown HIV infections were detected (prevalence=0.94%;95%CI=0.69-1.24). The prevalence was somewhat higher in DC requests (30 cas-es 1.12%) than the rest (18 cases 0.71%; p=0.16). The individualized prevalence of CD reasons ranged between 7.41% (95%CI=0.91-24.3) in chemsex and 0.42% 95%CI=0.14-0.98) in PPE, always efficient except herpes zoster (0.76%; CI95%=0.02-4.18). In other reasons, cases were detected in 12 circumstances, and in four the determination could be efficient: lymphopenia (10%;CI95%=0.25-44.5), fever with polyarthralgia-polyarthritis (7.41%;CI95% =0.91-24.3), behavioral alteration-confusion-encephalopathy (3.45%;95%CI=0.42-11.9) and fever of unknown origin (2.50%;95%CI=0.82-5.74).</p><p><strong>Conclusions: </strong>The determination of HIV serology in HES in the processes defined by DC SEMES-GESIDA is efficient. Some circumstances are identified that could be added to those previously contemplated to increase efficiency.</p>","PeriodicalId":21232,"journal":{"name":"Revista Espanola De Quimioterapia","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/67/60/revespquimioter-36-169.PMC10066909.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9591273","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
[Microbial etiology of bacterial chronic prostatitis: systematic review]. 细菌性慢性前列腺炎的微生物病因学:系统综述。
IF 1.9 4区 医学 Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2023-04-01 DOI: 10.37201/req/099.2022
R Mendoza-Rodríguez, I Hernández-Chico, B Gutiérrez-Soto, J M Navarro-Marí, J Gutiérrez-Fernández

Objective: The importance of Gram-positive microorganisms and atypical bacteria in chronic bacterial prostatitis (CBP) has recently been described. For this reason, this study analyzes the etiology of CBP, as well as the evolution of antibiotic resistance through a systematic review.

Methods: A systematic review of studies obtained through the MEDLINE (PubMed) database, related to the etiology and antibiotic resistance profile of CBP, published up July 1, 2021.

Results: The most frequent isolated microorganisms that we have found in publications are Enterococcus faecalis (46.90%), Staphylococcus spp. (22.30%), Escherichia coli (15.09%) and atypical bacteria (6.04%).

Conclusions: CBP is undergoing and unprecedented change of paradigm. Gram-positive bacteria and atypical bacteria are the main pathogens involved in the aetiology of this entity. This forces us to rethink the therapeutic strategy used, since it is necessary to use antibiotics that assume the etiological change and the profile of antibiotic resistance described.

目的:近年来研究革兰氏阳性微生物和非典型细菌在慢性细菌性前列腺炎(CBP)中的重要性。因此,本研究通过系统回顾分析CBP的病因,以及抗生素耐药性的演变。方法:系统回顾了通过MEDLINE (PubMed)数据库获得的有关CBP病因和抗生素耐药性的研究,发表于2021年7月1日。结果:在文献中分离到的最常见的微生物是粪肠球菌(46.90%)、葡萄球菌(22.30%)、大肠杆菌(15.09%)和非典型细菌(6.04%)。结论:海关海关正在经历前所未有的范式变革。革兰氏阳性细菌和非典型细菌是主要的病原体参与这个实体的病因学。这迫使我们重新思考所使用的治疗策略,因为有必要使用假定病原学变化和抗生素耐药性概况的抗生素。
{"title":"[Microbial etiology of bacterial chronic prostatitis: systematic review].","authors":"R Mendoza-Rodríguez,&nbsp;I Hernández-Chico,&nbsp;B Gutiérrez-Soto,&nbsp;J M Navarro-Marí,&nbsp;J Gutiérrez-Fernández","doi":"10.37201/req/099.2022","DOIUrl":"https://doi.org/10.37201/req/099.2022","url":null,"abstract":"<p><strong>Objective: </strong>The importance of Gram-positive microorganisms and atypical bacteria in chronic bacterial prostatitis (CBP) has recently been described. For this reason, this study analyzes the etiology of CBP, as well as the evolution of antibiotic resistance through a systematic review.</p><p><strong>Methods: </strong>A systematic review of studies obtained through the MEDLINE (PubMed) database, related to the etiology and antibiotic resistance profile of CBP, published up July 1, 2021.</p><p><strong>Results: </strong>The most frequent isolated microorganisms that we have found in publications are Enterococcus faecalis (46.90%), Staphylococcus spp. (22.30%), Escherichia coli (15.09%) and atypical bacteria (6.04%).</p><p><strong>Conclusions: </strong>CBP is undergoing and unprecedented change of paradigm. Gram-positive bacteria and atypical bacteria are the main pathogens involved in the aetiology of this entity. This forces us to rethink the therapeutic strategy used, since it is necessary to use antibiotics that assume the etiological change and the profile of antibiotic resistance described.</p>","PeriodicalId":21232,"journal":{"name":"Revista Espanola De Quimioterapia","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ae/8b/revespquimioter-36-144.PMC10066912.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9606459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
[Validity and usefulness of the RAE-CMBD studying patients hospitalised with influenza]. [RAE-CMBD研究流感住院患者的有效性和有用性]。
IF 1.9 4区 医学 Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2023-04-01 DOI: 10.37201/req/074.2022
V Quirós-González, J L Bernal, A M Haro-Pérez, J A Maderuelo-Fernández, M T Santos-Jiménez, N García-Barrio, A L Pavón-Muñoz, E López-Sánchez, M A García-Iglesias, P Serrano, J M Eiros

Objective: Understanding the hospital impact of influenza requires enriching epidemiological surveillance registries with other sources of information. The aim of this study was to determine the validity of the Hospital Care Activity Record - Minimum Basic Data Set (RAE-CMBD) in the analysis of the outcomes of patients hospitalised with this infection.

Methods: Observational and retrospective study of adults admitted with influenza in a tertiary hospital during the 2017/2018 and 2018/2019 seasons. We calculated the concordance of the RAE-CMBD with the influenza epidemiological surveillance registry (gold standard), as well as the main parameters of internal and external validity. Logistic regression models were used for risk adjustment of in-hospital mortality and length of stay.

Results: A total of 907 (97.74%) unique matches were achieved, with high inter-observer agreement (ƙ=0.828). The RAE-CMBD showed a 79.87% sensitivity, 99.72% specificity, 86.71% positive predictive value and 99.54% negative predictive value. The risk-adjusted mortality ratio of patients with influenza was lower than that of patients without influenza: 0.667 (0.53-0.82) vs. 1.008 (0.98-1.04) and the risk-adjusted length of stay ratio was higher: 1.15 (1.12-1.18) vs. 1.00 (0.996-1.001).

Conclusions: The RAE-CMBD is a valid source of information for the study of the impact of influenza on hospital care. The lower risk-adjusted mortality of patients admitted with influenza compared to other inpatients seems to point to the effectiveness of the main clinical and organisational measures adopted.

目的:了解流感对医院的影响需要利用其他信息来源丰富流行病学监测登记。本研究的目的是确定医院护理活动记录-最低基本数据集(RAE-CMBD)在分析因这种感染住院的患者结果中的有效性。方法:对某三级医院2017/2018年和2018/2019年流感季节住院的成人进行观察和回顾性研究。我们计算了RAE-CMBD与流感流行病学监测登记(金标准)的一致性,以及内部效度和外部效度的主要参数。采用Logistic回归模型对住院死亡率和住院时间进行风险调整。结果:共获得907例(97.74%)独特匹配,观察者间一致性高( =0.828)。RAE-CMBD的敏感性为79.87%,特异性为99.72%,阳性预测值为86.71%,阴性预测值为99.54%。流感患者的风险校正死亡率低于非流感患者,分别为0.667(0.53-0.82)和1.008(0.98-1.04);流感患者的风险校正住院时间比更高,分别为1.15(1.12-1.18)和1.00(0.996-1.001)。结论:RAE-CMBD是研究流感对医院护理影响的有效信息来源。与其他住院患者相比,入院的流感患者的风险调整死亡率较低,这似乎表明所采取的主要临床和组织措施是有效的。
{"title":"[Validity and usefulness of the RAE-CMBD studying patients hospitalised with influenza].","authors":"V Quirós-González,&nbsp;J L Bernal,&nbsp;A M Haro-Pérez,&nbsp;J A Maderuelo-Fernández,&nbsp;M T Santos-Jiménez,&nbsp;N García-Barrio,&nbsp;A L Pavón-Muñoz,&nbsp;E López-Sánchez,&nbsp;M A García-Iglesias,&nbsp;P Serrano,&nbsp;J M Eiros","doi":"10.37201/req/074.2022","DOIUrl":"https://doi.org/10.37201/req/074.2022","url":null,"abstract":"<p><strong>Objective: </strong>Understanding the hospital impact of influenza requires enriching epidemiological surveillance registries with other sources of information. The aim of this study was to determine the validity of the Hospital Care Activity Record - Minimum Basic Data Set (RAE-CMBD) in the analysis of the outcomes of patients hospitalised with this infection.</p><p><strong>Methods: </strong>Observational and retrospective study of adults admitted with influenza in a tertiary hospital during the 2017/2018 and 2018/2019 seasons. We calculated the concordance of the RAE-CMBD with the influenza epidemiological surveillance registry (gold standard), as well as the main parameters of internal and external validity. Logistic regression models were used for risk adjustment of in-hospital mortality and length of stay.</p><p><strong>Results: </strong>A total of 907 (97.74%) unique matches were achieved, with high inter-observer agreement (ƙ=0.828). The RAE-CMBD showed a 79.87% sensitivity, 99.72% specificity, 86.71% positive predictive value and 99.54% negative predictive value. The risk-adjusted mortality ratio of patients with influenza was lower than that of patients without influenza: 0.667 (0.53-0.82) vs. 1.008 (0.98-1.04) and the risk-adjusted length of stay ratio was higher: 1.15 (1.12-1.18) vs. 1.00 (0.996-1.001).</p><p><strong>Conclusions: </strong>The RAE-CMBD is a valid source of information for the study of the impact of influenza on hospital care. The lower risk-adjusted mortality of patients admitted with influenza compared to other inpatients seems to point to the effectiveness of the main clinical and organisational measures adopted.</p>","PeriodicalId":21232,"journal":{"name":"Revista Espanola De Quimioterapia","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4c/1f/revespquimioter-36-160.PMC10066910.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9243241","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Extensively drug-resistant tuberculosis treated with bedaquiline]. [用贝达喹啉治疗广泛耐药结核病]。
IF 1.9 4区 医学 Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2023-04-01 DOI: 10.37201/req/073.2022
A López Pérez, H Navarro Aznarez, A Pinilla Rello, J Perales Pascual, P Arazo Garcés
{"title":"[Extensively drug-resistant tuberculosis treated with bedaquiline].","authors":"A López Pérez,&nbsp;H Navarro Aznarez,&nbsp;A Pinilla Rello,&nbsp;J Perales Pascual,&nbsp;P Arazo Garcés","doi":"10.37201/req/073.2022","DOIUrl":"https://doi.org/10.37201/req/073.2022","url":null,"abstract":"","PeriodicalId":21232,"journal":{"name":"Revista Espanola De Quimioterapia","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/33/b2/revespquimioter-36-201.PMC10066908.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9237405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Brain abscesses caused by anaerobic microorganisms: a systematic review. 厌氧微生物引起的脑脓肿:系统综述。
IF 1.9 4区 医学 Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2023-04-01 DOI: 10.37201/req/114.2022
F Cobo

The objective of this study was to perform a systematic review of the characteristics, causative microorganisms and outcome of brain abscesses caused by anaerobic bacteria over the past 25 years. We reviewed studies on brain abscesses which included infection due to anaerobic microorganisms published between 1998 and 2022. We excluded reports with polymicrobial infections (more than 2 anaerobic bacteria isolated) and those that do not provide enough information to make comparisons, the reports with only one case of brain abscess due to anaerobes, as well as those focused on an only anaerobic bacterium. Also, we have excluded the cases in pediatric population. We searched the scientific literature through the Cochrane Library, EMBASE and PubMed/MEDLINE databases for studies of this condition. We finally included 28 studies with 6,167 patients, of which 715 (11.5%) were cases caused by anaerobic bacteria. There was a male predominance (70%) and mean age of 40.3 years. Most infections were monomicrobial (59.4%). The most common anaerobic microorganisms isolated were Bacteroides spp (43.4%) and Gram-positive anaerobic cocci (35.1%). Cases of brain abscesses caused by anaerobic bacteria were most frequent in Asia and Europe. The source of infection most frequent was otogenic in 84.6% followed by a neurosurgery procedure infection in 23% of patients. The main symptom observed was headache in 95.6% of patients followed by fever (69.5%). Surgical treatment was performed in 48 % of patients and the percentage of patients in whom antibiotic treatment was applied range 88.8% to 100%. The main limitation of this review is the non-inclusion of studies published before of 1998 in which MALDI-TOF MS system had not been introduced in the majority of laboratories for routine identification. The patient rate with isolation of anaerobic bacteria in brain abscesses is low, but these data could be underestimated mainly due to the fastidious nature of these microorganisms and the difficulties in the identification of some anaerobes.

本研究的目的是对过去25年来由厌氧菌引起的脑脓肿的特征、致病微生物和结果进行系统回顾。我们回顾了1998年至2022年间发表的关于脑脓肿的研究,其中包括厌氧微生物引起的感染。我们排除了多微生物感染(分离出2种以上厌氧菌)的报告和那些没有提供足够信息进行比较的报告,那些只有一例厌氧菌引起的脑脓肿的报告,以及那些只关注一种厌氧菌的报告。此外,我们还排除了儿童人群中的病例。我们通过Cochrane图书馆、EMBASE和PubMed/MEDLINE数据库检索了有关这种情况的科学文献。我们最终纳入了28项研究,共6167例患者,其中715例(11.5%)为厌氧菌引起的病例。男性居多(70%),平均年龄40.3岁。感染以单菌感染为主(59.4%)。最常见的厌氧微生物为拟杆菌(43.4%)和革兰氏阳性厌氧球菌(35.1%)。由厌氧菌引起的脑脓肿病例在亚洲和欧洲最为常见。感染最常见的来源是耳源性感染(84.6%),其次是神经外科手术感染(23%)。主要症状为头痛(95.6%),其次为发热(69.5%)。48%的患者接受了手术治疗,使用抗生素治疗的患者比例为88.8%至100%。本综述的主要局限性是未纳入1998年以前发表的研究,在这些研究中,大多数实验室尚未采用MALDI-TOF质谱系统进行常规鉴定。脑脓肿患者分离厌氧菌的比例很低,但这些数据可能被低估,主要是由于这些微生物的挑剔性质和一些厌氧菌的鉴定困难。
{"title":"Brain abscesses caused by anaerobic microorganisms: a systematic review.","authors":"F Cobo","doi":"10.37201/req/114.2022","DOIUrl":"https://doi.org/10.37201/req/114.2022","url":null,"abstract":"<p><p>The objective of this study was to perform a systematic review of the characteristics, causative microorganisms and outcome of brain abscesses caused by anaerobic bacteria over the past 25 years. We reviewed studies on brain abscesses which included infection due to anaerobic microorganisms published between 1998 and 2022. We excluded reports with polymicrobial infections (more than 2 anaerobic bacteria isolated) and those that do not provide enough information to make comparisons, the reports with only one case of brain abscess due to anaerobes, as well as those focused on an only anaerobic bacterium. Also, we have excluded the cases in pediatric population. We searched the scientific literature through the Cochrane Library, EMBASE and PubMed/MEDLINE databases for studies of this condition. We finally included 28 studies with 6,167 patients, of which 715 (11.5%) were cases caused by anaerobic bacteria. There was a male predominance (70%) and mean age of 40.3 years. Most infections were monomicrobial (59.4%). The most common anaerobic microorganisms isolated were Bacteroides spp (43.4%) and Gram-positive anaerobic cocci (35.1%). Cases of brain abscesses caused by anaerobic bacteria were most frequent in Asia and Europe. The source of infection most frequent was otogenic in 84.6% followed by a neurosurgery procedure infection in 23% of patients. The main symptom observed was headache in 95.6% of patients followed by fever (69.5%). Surgical treatment was performed in 48 % of patients and the percentage of patients in whom antibiotic treatment was applied range 88.8% to 100%. The main limitation of this review is the non-inclusion of studies published before of 1998 in which MALDI-TOF MS system had not been introduced in the majority of laboratories for routine identification. The patient rate with isolation of anaerobic bacteria in brain abscesses is low, but these data could be underestimated mainly due to the fastidious nature of these microorganisms and the difficulties in the identification of some anaerobes.</p>","PeriodicalId":21232,"journal":{"name":"Revista Espanola De Quimioterapia","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1f/12/revespquimioter-36-152.PMC10066918.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9238071","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Vitamin C and thiamine for the treatment of refractory septic shock in surgical critically ill patients: a retrospective before-and-after study. 维生素 C 和硫胺素用于治疗外科重症患者的难治性脓毒性休克:一项前后回顾性研究。
IF 1.9 4区 医学 Q4 MICROBIOLOGY Pub Date : 2023-04-01 Epub Date: 2022-11-28 DOI: 10.37201/req/107.2022
A Suárez-de-la-Rica, B Croes, L Ciudad, I Vallejo, J Mújica, M Díaz-Almirón, E Maseda

Objective: This study aimed to evaluate whether early vitamin C and thiamine administration was associated with a lower 28-day and in-hospital mortality in surgical critically ill patients with refractory septic shock.

Methods: We performed a retrospective before-and-after study on patients with refractory septic shock. According to local protocol, hydrocortisone is initiated in case of refractory septic shock. In January 2017, the protocol was changed and vitamin C and thiamine were included. Patients who were admitted in 2015-2016 and 2017-2018 were included in the control and treatment groups, respectively. The primary end point was 28-day and in-hospital mortality. Secondary end points were ICU mortality, ICU and hospital length of stay, duration of vasopressors and mechanical ventilation, use of renal replacement therapy (RRT), and the modification in serum procalcitonin and SOFA score during the first 72 h.

Results: A total of 120 patients were included (58 in the treatment group and 62 in the control group). Log-rank test in Kaplan-Meier curves showed lower 28-day and in-hospital mortality over time in the treatment group (p=0.021 and p=0.035, respectively) but it not reached statistical significance in ICU mortality over time (p=0.100). The need of RRT was less frequent in treatment group (17.2% vs. 37.1%, p=0.024). There were no differences in other secondary outcomes.

Conclusions: Intravenous vitamin C and thiamine administration in surgical patients with refractory septic shock may be associated with a lower 28-day and in-hospital mortality. Further prospective studies are needed in refractory septic shock.

研究目的本研究旨在评估早期服用维生素 C 和硫胺素是否与降低难治性脓毒性休克外科重症患者 28 天和住院期间的死亡率有关:我们对难治性脓毒性休克患者进行了一项前后对比的回顾性研究。根据当地的治疗方案,难治性脓毒性休克患者可开始使用氢化可的松。2017年1月,该方案有所改变,维生素C和硫胺素被纳入其中。2015-2016年和2017-2018年入院的患者分别被纳入对照组和治疗组。主要终点是28天和院内死亡率。次要终点为重症监护室死亡率、重症监护室和住院时间、使用血管加压药和机械通气的时间、肾脏替代疗法(RRT)的使用以及头72小时内血清降钙素原和SOFA评分的变化:共纳入120名患者(治疗组58人,对照组62人)。Kaplan-Meier曲线的对数秩检验显示,治疗组的28天死亡率和院内死亡率随着时间的推移而降低(分别为p=0.021和p=0.035),但ICU死亡率随着时间的推移没有达到统计学意义(p=0.100)。治疗组对 RRT 的需求较少(17.2% 对 37.1%,P=0.024)。其他次要结果无差异:结论:对难治性脓毒性休克的手术患者静脉注射维生素 C 和硫胺素可能会降低 28 天死亡率和院内死亡率。需要对难治性脓毒性休克进行进一步的前瞻性研究。
{"title":"Vitamin C and thiamine for the treatment of refractory septic shock in surgical critically ill patients: a retrospective before-and-after study.","authors":"A Suárez-de-la-Rica, B Croes, L Ciudad, I Vallejo, J Mújica, M Díaz-Almirón, E Maseda","doi":"10.37201/req/107.2022","DOIUrl":"10.37201/req/107.2022","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to evaluate whether early vitamin C and thiamine administration was associated with a lower 28-day and in-hospital mortality in surgical critically ill patients with refractory septic shock.</p><p><strong>Methods: </strong>We performed a retrospective before-and-after study on patients with refractory septic shock. According to local protocol, hydrocortisone is initiated in case of refractory septic shock. In January 2017, the protocol was changed and vitamin C and thiamine were included. Patients who were admitted in 2015-2016 and 2017-2018 were included in the control and treatment groups, respectively. The primary end point was 28-day and in-hospital mortality. Secondary end points were ICU mortality, ICU and hospital length of stay, duration of vasopressors and mechanical ventilation, use of renal replacement therapy (RRT), and the modification in serum procalcitonin and SOFA score during the first 72 h.</p><p><strong>Results: </strong>A total of 120 patients were included (58 in the treatment group and 62 in the control group). Log-rank test in Kaplan-Meier curves showed lower 28-day and in-hospital mortality over time in the treatment group (p=0.021 and p=0.035, respectively) but it not reached statistical significance in ICU mortality over time (p=0.100). The need of RRT was less frequent in treatment group (17.2% vs. 37.1%, p=0.024). There were no differences in other secondary outcomes.</p><p><strong>Conclusions: </strong>Intravenous vitamin C and thiamine administration in surgical patients with refractory septic shock may be associated with a lower 28-day and in-hospital mortality. Further prospective studies are needed in refractory septic shock.</p>","PeriodicalId":21232,"journal":{"name":"Revista Espanola De Quimioterapia","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6d/bf/revespquimioter-36-187.PMC10066916.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9605938","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Insights for COVID-19 in 2023. 2023 年 COVID-19 的洞察力。
IF 1.9 4区 医学 Q4 MICROBIOLOGY Pub Date : 2023-04-01 Epub Date: 2022-12-13 DOI: 10.37201/req/122.2022
F J Martín Sánchez, M Martínez-Sellés, J M Molero García, S Moreno Guillén, F J Rodríguez-Artalejo, J Ruiz-Galiana, R Cantón, P De Lucas Ramos, A García-Botella, A García-Lledó, T Hernández-Sampelayo, J Gómez-Pavón, J González Del Castillo, M C Martín-Delgado, E Bouza

Predictions for a near end of the pandemic by the World Health Organization should be interpreted with caution. Current evidence indicates that the efficacy of a fourth dose of classical mRNA vaccines (BT162b2 or mRNA-1273) is low and short-lived in preventing SARS-CoV-2 infection in its predominant variant (Omicron). However, its efficacy is high against severe symptomatic infection, hospitalization and death. The new vaccines being introduced are bivalent and active against the Omicron variants. Potential new vaccines to be introduced in the coming year include a vaccine based on a recombinant protein that emulates the receptor binding domain of the Spike protein under development by the Spanish company Hipra, as well as vaccines for nasal or oral administration. Available information suggests that vaccines against COVID-19 can be administered in association with influenza vaccination without particular complications. New drugs against COVID-19, both antiviral and anti-inflammatory, are under investigation, but this does not seem to be the case with monoclonal antibodies. The indication to use masks in some circumstances will be maintained next year in view of the accumulation of scientific data on their efficacy. Finally, the long COVID or Post-COVID syndrome may continue to affect a very high proportion of patients who have had the disease, requiring combined diagnostic and therapeutic resources.

世界卫生组织关于大流行即将结束的预测应谨慎解读。目前的证据表明,第四剂经典 mRNA 疫苗(BT162b2 或 mRNA-1273)在预防 SARS-CoV-2 主要变种(Omicron)感染方面的效力较低且持续时间较短。然而,它对无症状的严重感染、住院和死亡的预防效果却很高。正在引进的新疫苗是二价疫苗,对 Omicron 变体具有活性。明年可能推出的新疫苗包括西班牙 Hipra 公司正在开发的一种基于重组蛋白的疫苗(该重组蛋白可模拟 Spike 蛋白的受体结合域),以及用于鼻腔或口腔给药的疫苗。现有资料表明,COVID-19 疫苗可与流感疫苗同时接种,不会产生特别的并发症。针对 COVID-19 的抗病毒和抗炎新药正在研究中,但单克隆抗体似乎并非如此。鉴于有关口罩疗效的科学数据不断积累,明年将保留在某些情况下使用口罩的指征。最后,长期 COVID 或后 COVID 综合征可能会继续影响很高比例的患者,需要综合诊断和治疗资源。
{"title":"Insights for COVID-19 in 2023.","authors":"F J Martín Sánchez, M Martínez-Sellés, J M Molero García, S Moreno Guillén, F J Rodríguez-Artalejo, J Ruiz-Galiana, R Cantón, P De Lucas Ramos, A García-Botella, A García-Lledó, T Hernández-Sampelayo, J Gómez-Pavón, J González Del Castillo, M C Martín-Delgado, E Bouza","doi":"10.37201/req/122.2022","DOIUrl":"10.37201/req/122.2022","url":null,"abstract":"<p><p>Predictions for a near end of the pandemic by the World Health Organization should be interpreted with caution. Current evidence indicates that the efficacy of a fourth dose of classical mRNA vaccines (BT162b2 or mRNA-1273) is low and short-lived in preventing SARS-CoV-2 infection in its predominant variant (Omicron). However, its efficacy is high against severe symptomatic infection, hospitalization and death. The new vaccines being introduced are bivalent and active against the Omicron variants. Potential new vaccines to be introduced in the coming year include a vaccine based on a recombinant protein that emulates the receptor binding domain of the Spike protein under development by the Spanish company Hipra, as well as vaccines for nasal or oral administration. Available information suggests that vaccines against COVID-19 can be administered in association with influenza vaccination without particular complications. New drugs against COVID-19, both antiviral and anti-inflammatory, are under investigation, but this does not seem to be the case with monoclonal antibodies. The indication to use masks in some circumstances will be maintained next year in view of the accumulation of scientific data on their efficacy. Finally, the long COVID or Post-COVID syndrome may continue to affect a very high proportion of patients who have had the disease, requiring combined diagnostic and therapeutic resources.</p>","PeriodicalId":21232,"journal":{"name":"Revista Espanola De Quimioterapia","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1a/41/revespquimioter-36-114.PMC10066911.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9236932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of the COVID-19 pandemic on the mental health of the general population and health care workers. COVID-19大流行对普通人群和卫生保健工作者心理健康的影响。
IF 1.9 4区 医学 Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2023-04-01 DOI: 10.37201/req/018.2023
E Bouza, C Arango, C Moreno, D Gracia, M Martín, V Pérez, L Lázaro, F Ferre, G Salazar, F Tejerina-Picado, M Navío, J Granda Revilla, E Palomo, P R Gil-Monte

The Health Sciences Foundation has assembled a multidisciplinary group around a series of questions about the impact of the COVID-19 pandemic on the mental health of the general population and specific groups within that population, particularly healthcare workers. In the general population, the most prevalent mental disorders have been anxiety, sleep disorders and affective disorders, primarily depression. There has been a considerable increase in suicidal behavior, especially in young women and men over 70 years of age. There has been an increase in alcohol abuse and nicotine, cannabis and cocaine use. In contrast, the use of synthetic stimulants during periods of confinement has decreased. With regard to non-substance addictions, gambling was very limited, pornography consumption increased significantly and there was an increase in compulsive shopping and the use of video games. Particularly vulnerable groups include adolescents and patients with autism spectrum disorders. Healthcare workers suffered an increase in depression, anxiety and post-traumatic stress, especially those who were exposed during the early stages of the pandemic. Female sex, being a nurse, proximity to patients with COVID-19, working in a rural environment and having previous psychiatric or organic illnesses were some of the most frequently repeated factors in various studies in this population group. The media have shown a good degree of knowledge about these problems and have dealt with them frequently and from the point of view of ethics, crisis situations, such as the one experienced, have triggered not only physical but also moral claudications.

健康科学基金会组建了一个多学科小组,围绕一系列关于COVID-19大流行对普通人群和人群中特定群体(特别是医护人员)心理健康影响的问题。在一般人群中,最普遍的精神障碍是焦虑、睡眠障碍和情感障碍,主要是抑郁症。自杀行为有相当大的增加,尤其是在70岁以上的年轻女性和男性中。酗酒和使用尼古丁、大麻和可卡因的情况有所增加。相比之下,在监禁期间使用合成兴奋剂的情况有所减少。在非物质成瘾方面,赌博非常有限,色情消费显著增加,强迫性购物和视频游戏的使用有所增加。特别脆弱的群体包括青少年和自闭症谱系障碍患者。卫生保健工作者的抑郁、焦虑和创伤后压力增加,特别是那些在大流行早期阶段接触过病毒的人。女性、担任护士、接近COVID-19患者、在农村环境中工作以及以前患有精神或器质性疾病是该人群中各种研究中最常见的一些重复因素。媒体对这些问题表现出相当的了解,并经常处理这些问题,从道德的角度来看,危机局势,例如所经历的危机局势,不仅造成了身体上的残疾,而且造成了道德上的残疾。
{"title":"Impact of the COVID-19 pandemic on the mental health of the general population and health care workers.","authors":"E Bouza,&nbsp;C Arango,&nbsp;C Moreno,&nbsp;D Gracia,&nbsp;M Martín,&nbsp;V Pérez,&nbsp;L Lázaro,&nbsp;F Ferre,&nbsp;G Salazar,&nbsp;F Tejerina-Picado,&nbsp;M Navío,&nbsp;J Granda Revilla,&nbsp;E Palomo,&nbsp;P R Gil-Monte","doi":"10.37201/req/018.2023","DOIUrl":"https://doi.org/10.37201/req/018.2023","url":null,"abstract":"<p><p>The Health Sciences Foundation has assembled a multidisciplinary group around a series of questions about the impact of the COVID-19 pandemic on the mental health of the general population and specific groups within that population, particularly healthcare workers. In the general population, the most prevalent mental disorders have been anxiety, sleep disorders and affective disorders, primarily depression. There has been a considerable increase in suicidal behavior, especially in young women and men over 70 years of age. There has been an increase in alcohol abuse and nicotine, cannabis and cocaine use. In contrast, the use of synthetic stimulants during periods of confinement has decreased. With regard to non-substance addictions, gambling was very limited, pornography consumption increased significantly and there was an increase in compulsive shopping and the use of video games. Particularly vulnerable groups include adolescents and patients with autism spectrum disorders. Healthcare workers suffered an increase in depression, anxiety and post-traumatic stress, especially those who were exposed during the early stages of the pandemic. Female sex, being a nurse, proximity to patients with COVID-19, working in a rural environment and having previous psychiatric or organic illnesses were some of the most frequently repeated factors in various studies in this population group. The media have shown a good degree of knowledge about these problems and have dealt with them frequently and from the point of view of ethics, crisis situations, such as the one experienced, have triggered not only physical but also moral claudications.</p>","PeriodicalId":21232,"journal":{"name":"Revista Espanola De Quimioterapia","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/83/0d/revespquimioter-36-125.PMC10066913.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9607020","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Soft-tissue infection due to Mycoplasma hominis. 人支原体引起的软组织感染。
IF 1.9 4区 医学 Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2023-04-01 DOI: 10.37201/req/115.2022
A Ruiz Castillo, E López Herrero, A Tenorio Abreu, A González Gómez-Lozano, J M Saavedra Martín
Gram staining of the right hand dorsum collection showed numerous polymorphonuclear leukocytes and no visible microorganisms. However, 4 days of incubation on blood agar at 35°C under 5% CO2 resulted in the formation of pinpoint-sized colonies resembling water droplets. These colonies could not be identified by matrix-assisted laser desorption ionization– time of flight mass spectrometry (MALDI-TOF MS) (“no peaks found”). Gram and Ziehl–Nielsen stainings performed on the colonies showed no bacteria. These results led us to suspect Mycoplasma spp, and the culture were transferred to Reference Laboratory for ARNr16s PCR and subsequent sequencing, where this microorganism was detected and identified.
{"title":"Soft-tissue infection due to Mycoplasma hominis.","authors":"A Ruiz Castillo,&nbsp;E López Herrero,&nbsp;A Tenorio Abreu,&nbsp;A González Gómez-Lozano,&nbsp;J M Saavedra Martín","doi":"10.37201/req/115.2022","DOIUrl":"https://doi.org/10.37201/req/115.2022","url":null,"abstract":"Gram staining of the right hand dorsum collection showed numerous polymorphonuclear leukocytes and no visible microorganisms. However, 4 days of incubation on blood agar at 35°C under 5% CO2 resulted in the formation of pinpoint-sized colonies resembling water droplets. These colonies could not be identified by matrix-assisted laser desorption ionization– time of flight mass spectrometry (MALDI-TOF MS) (“no peaks found”). Gram and Ziehl–Nielsen stainings performed on the colonies showed no bacteria. These results led us to suspect Mycoplasma spp, and the culture were transferred to Reference Laboratory for ARNr16s PCR and subsequent sequencing, where this microorganism was detected and identified.","PeriodicalId":21232,"journal":{"name":"Revista Espanola De Quimioterapia","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/58/07/revespquimioter-36-220.PMC10066921.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9607019","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Revista Espanola De Quimioterapia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1